# Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia

> **NCT07572656** · NA · COMPLETED · sponsor: **Muhammad Aamir Latif** · enrollment: 132 (actual)

## Conditions studied

- Preeclampsia

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Hydralazine

## Key facts

- **NCT ID:** NCT07572656
- **Lead sponsor:** Muhammad Aamir Latif
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07572656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07572656, "Comparison of Intravenous Labetalol and Intravenous Hydralazine in Severe Preeclampsia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07572656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*